21/05/2021 |
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
CIM |
Registered outdated |
21/05/2021 |
Nimotuzumab in COVID-19 |
CIM |
Registered |
21/06/2023 |
VSSPs in renal carcinoma. |
CIM |
Registered |
21/07/2023 |
Safety of Orally Administered Neutral pH Super Oxidation Electrolyzed Solution |
SSA |
Registered |
21/12/2020 |
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study |
BIOCEN |
Registered |
22/01/2021 |
Curmeric- Safety-Community-Quarantine-COVID-19 |
CEADEN |
Registered outdated |
22/01/2021 |
Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19 |
CEADEN |
Registered outdated |
22/01/2021 |
Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19 |
CEADEN |
Registered outdated |
22/04/2014 |
Totally Laparoscopic Hysterectomy with Single-Port Access. Validation of a new technique in Cuba. |
CNCMA |
Registered |
22/04/2016 |
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II |
CIM |
Registered |
22/05/2015 |
Itolizumab for Relapsing Remitting Multiple Sclerosis |
CIM |
Registered |
22/05/2015 |
Safety and pharmacokinetics of CIGB-552 |
CIGB |
Registered |
22/05/2020 |
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study |
FINLAY |
Registered outdated |
22/05/2020 |
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 |
FINLAY |
Registered |
22/05/2021 |
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
CIM |
Registered outdated |
22/05/2021 |
Abexol (suspension) versus Abexol (tablets) in patients with gastrointestinal symptoms |
CPN |
Registered outdated |
22/06/2020 |
VIDA study |
CIGB |
Registered outdated |
22/08/2013 |
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) |
CIGB |
Registered |
22/09/2022 |
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
CIM |
Registered |
22/10/2018 |
DENIS Study |
CIGB |
Registered outdated |